|
STAND UP TO CANCER RETURNS FOR FIFTH LIVE ROADBLOCK TELECAST
FRIDAY, SEPTEMBER 9
BRADLEY COOPER TO EXECUTIVE-PRODUCE
WITH AWARD-WINNING TEAM AT DONE + DUSTED
LIVE, ONE-HOUR FUNDRAISING EVENT TO AIR
SIMULTANEOUSLY ON ABC, CBS, FOX, NBC
AND OVER 45 BROADCAST AND CABLE NETWORKS IN THE U.S. AND
CANADA
8:00 PM ET AND PT / 7:00 PM CT
http://www.standup2cancer.org | facebook.com/su2c |
Instagram: @SU2C |
Twitter: @SU2C
The Hollywood community is once again uniting to support Stand
Up To Cancer (SU2C), a
program of the Entertainment
Industry Foundation (EIF), which
will stage its fifth biennial televised fundraising special
on Friday, Sept. 9 (8:00 – 9:00 PM ET/PT / 7:00 PM CT).
Academy Award-nominated actor and founder of the Charles J
Cooper Patient Support Fund, Bradley
Cooper, will
serve as executive producer along with renowned live,
large-scale event producers Done
+ Dusted, working
with Stand
Up To Cancer’s production team. Additional stars and
performers will be announced in the coming weeks.
The telecast will broadcast live
from The
Music Center’s Walt Disney Concert Hall in
downtown Los Angeles. ABC,
CBS, FOX, and NBC, along
with American
Forces Network, ASPiRE, AUDIENCE Network, Bloomberg TV,
Bravo, Comedy Central, Discovery Life, EPIX, ESPNEWS, FM,
FS2, FXM, Great American Country, HBO, HBO Latino, HLN, ION
Television, LMN, Logo, MLB Network, National Geographic,
Pivot, RLTV, SHOWTIME, Smithsonian Channel, STARZ, STARZ
ENCORE, STARZ ENCORE ESPAÑOL, TBS, Tr3s, VH1, and WGN
America are
donating one hour of simultaneous commercial-free primetime
for the telecast. In addition, the show will stream live on Yahoo and MLB.com, and
will be available on Hulu.
“No one is ever fully prepared to deal with the overwhelming
and complex journey that comes with a cancer diagnosis,”
said Bradley Cooper, who lost his father, Charles Cooper, to
lung cancer in 2011. “Stand Up To Cancer works tirelessly to
support those at the forefront of the fight against cancer.
SU2C’s mission, to ensure that all cancer patients become
cancer survivors, is one that is very close to my heart. I
am proud to join forces to make this vision a reality and to
be part of this movement that is dedicated to getting
lifesaving treatments to cancer patients faster.”
To date, more than $370 million has been
pledged to support SU2C’s innovative model of collaborative
cancer research. Since launching in 2008, Stand Up To Cancer
has brought together more than 1,100 of the best and the
brightest research scientists from 131 leading institutions
in seven countries to work together on 19 “Dream Teams,” and
six Translational Research Teams. SU2C has also funded 36
early-career, innovative scientists carrying out high-risk,
potentially high-reward projects. The research is aimed at
ending cancer’s reign as a leading cause of death worldwide.
SU2C-funded researchers have planned, launched or completed
more than 160 clinical trials involving over 8,000 patients.
Work by SU2C-supported
researchers has led to FDA approval of two treatments.
In the United States, 84 percent of all cancer cases and 78
percent of all cancer deaths are from cancers included in
the SU2C research portfolio. One
in two men and one in three women in the U.S. are expected
to be diagnosed with cancer in their lifetimes, and almost
eight million people worldwide die from cancer every year.
“Stand Up To Cancer has come so far since
2008,” said Katie Couric, SU2C co-founder, who will also
participate in the telecast. “This effort has shown the true
power of teamwork. I am so grateful for the continued
support of the entertainment community, companies,
organizations, our non-profit collaborators, and everyday
people who have been touched by this disease, just as I have
been. Thanks to their commitment, compassion and generosity,
scientists are developing more effective therapies for so
many cancer patients.”
In addition to Couric, current members of the SU2C Council
of Founders and Advisors (CFA) include Sherry Lansing, Lisa
Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams,
Ellen Ziffren, and Kathleen Lobb. The late Laura Ziskin, who
was also a co-founder, executive produced both the 2008 and
2010 telecasts. SU2C was formally launched on May 27, 2008.
Sung Poblete, Ph.D., R.N., has served as SU2C’s president
since 2011.
In the past eight years, hundreds of celebrities have shown
their support for SU2C through extensive participation in
the biennial telecasts. Stars including Gwyneth
Paltrow, Julia
Roberts, Seth Rogen, Mike Myers, Samuel L. Jackson, Tom
Hanks, Michael Douglas, Matt Damon, Halle Berry, Justin
Timberlake, Jessica Alba, Robert Downey, Jr., Jon Hamm,
Taylor Swift, Anna Kendrick, Ben Stiller, Kerry Washington, and Katie
Couric have
taken part in these historic broadcasts. In
2014, musical performances included: The
Who, Ariana Grande, Dave Matthews Band, Lupe Fiasco,
Jennifer Hudson, and Common.
For the second time, Stand Up To Cancer
Canada will simultaneously broadcast the Canadian-inclusive
telecast across all four major English-language Canadian
broadcasters: CBC,
City, CTV, and Global. Additionally,
Canadian services AMI,
Bloomberg TV Canada, CHCH,
CHEK, Fight Network, Hollywood Suite, Joytv, NTV and TLN will
also air the telecast.
“We’re thrilled to be working with the amazing SU2C team on
one of the biggest telecasts in the industry calendar,” said
Hamish Hamilton, Director and Executive Producer at Done +
Dusted, who will direct the telecast. “It’s a rare privilege
to work on a show that combines the highest levels of
entertainment and talent with the opportunity to contribute
to the greater good of humanity,” added Ian Stewart,
President of Done + Dusted. Earlier this year, Hamilton
directed the Super Bowl 50 Halftime Show starring Coldplay
and featuring Bruno Mars and Beyoncé. He has received two
BAFTA Awards, a Peabody Award, and both Grammy and Emmy
Award nominations.
The first four SU2C telecasts took place on
Sept. 5, 2008, Sept. 10, 2010, Sept. 7, 2012, and Sept. 5,
2014 and were made available to more than 190 countries.
The first Canadian-inclusive SU2C telecast aired in 2014.
SU2C is a major force in immunotherapy, one
of the most promising developments in cancer research today,
which empowers the body’s own immune system to fight cancer
cells. SU2C is supporting advancements in immunotherapy
treatments for leukemia, melanoma, and cancers of the
pancreas, head and neck, lung, and ovary. SU2C also supports
development of precision therapies tailored to each
patient's genetic makeup in prostate cancer, melanoma, and
other cancers; and new technology to accelerate research,
early detection of colorectal cancer, prevention of ovarian
cancer, and groundbreaking work on cancer stem cells and the
epigenetics (processes that control so-called “packaging” of
DNA) of cancer, among other new fields.
The American Association for Cancer Research
(AACR), the world’s first and largest professional
organization dedicated to advancing cancer research, is the
official Scientific Partner of Stand Up To Cancer. In the
United States, AACR is responsible for administering the
grants and providing scientific oversight in conjunction
with the SU2C Scientific Advisory Committee (SAC). The SAC
is led by Chairperson and Nobel Laureate Phillip A. Sharp,
Ph.D., Institute Professor at the Massachusetts Institute of
Technology (MIT) and David H. Koch Institute for Integrative
Cancer Research at MIT. Vice chairs of the SAC are Arnold J.
Levine, Ph.D., professor emeritus of systems biology at the
Institute for Advanced Study in Princeton, New Jersey; and
William G. Nelson, M.D., Ph.D., director of the Johns
Hopkins Sidney Kimmel Comprehensive Cancer Center in
Baltimore. In Canada, the AACR International – Canada,
serves as official Scientific Partner of Stand Up To Cancer
Canada, which launched in 2014.The SU2C Canada Scientific
Advisory Committee is co-chaired
by Alan Bernstein O.C., Ph.D.,
president and chief executive officer of the Canadian
Institute for Advanced Research (CIFAR) and
Dr. Sharp.
As SU2C’s founding donor, Major League
Baseball has provided both financial support and countless
opportunities to build the Stand Up To Cancer grassroots
movement by encouraging fans worldwide to get involved. In
addition to MLB, SU2C’s “Visionary” donors include
Bristol-Myers Squibb Company; Cancer Treatment Centers of
America; Genentech, a member of the Roche Group; MasterCard;
and The Sidney Kimmel Foundation. Major donors and
collaborators include American Airlines, American Cancer
Society, CVS Health, Fifth Third Bank, The Lustgarten
Foundation for Pancreatic Cancer Research, Merck, and Rally
Health. Other key supporters and collaborators include
Cancer Research Institute, Cancer Research UK, Dutch Cancer
Society, Farrah Fawcett Foundation, Lilly Oncology, The
Laura Ziskin Family Trust, Melanoma Research Alliance,
National Ovarian Cancer Coalition, Ovarian Cancer Research
Fund Alliance, The Parker Foundation, Prostate Cancer
Foundation, St. Baldrick’s Foundation and Van Andel Research
Institute.
Collaborators in the inaugural Stand Up To
Cancer Canada Dream Teams: Stand
Up To Cancer Canada – Canadian Breast Cancer Foundation
Breast Cancer Dream Team; and Stand Up To Cancer Canada
Cancer Stem Cell Dream Team include Canadian Breast Cancer
Foundation (CBCF), with support from CIBC; Canadian
Institutes of Health Research; Cancer Stem Cell Consortium;
Genome Canada; and the Ontario Institute for Cancer
Research. AstraZeneca Canada and MasterCard are the first
corporate supporters of SU2C Canada.
About Stand Up To Cancer
Stand Up To Cancer (SU2C) raises funds to accelerate the
pace of research to get new therapies to patients quickly
and save lives now. SU2C, a program of the Entertainment
Industry Foundation (EIF), a 501(c)(3) charitable
organization, was established in 2008 by film and media
leaders who utilize the industry’s resources to engage the
public in supporting a new, collaborative model of cancer
research, and to increase awareness about cancer prevention
as well as progress being made in the fight against the
disease. As SU2C’s scientific partner, the American
Association for Cancer Research (AACR) and a Scientific
Advisory Committee led by Nobel Laureate Phillip A. Sharp,
PhD, conduct rigorous, competitive review processes to
identify the best research proposals to recommend for
funding, oversee grants administration, and provide expert
review of research progress.
Current members of the SU2C Council of Founders and Advisors
(CFA) include Katie Couric, Sherry Lansing, Lisa Paulsen,
Rusty Robertson, Sue Schwartz, Pamela Oas Williams, Ellen
Ziffren, and Kathleen Lobb. The late Laura Ziskin was also a
co-founder. SU2C was formally launched on May 27, 2008. Sung
Poblete, Ph.D., R.N., has served as SU2C’s president since
2011.
For more information on Stand Up To Cancer, visit www.standup2cancer.org.
About the Entertainment Industry Foundation
Founded in 1942, the Entertainment Industry
Foundation (EIF) is a multifaceted organization that
occupies a unique place in the world of philanthropy. By
mobilizing and leveraging the powerful voice and creative
talents of the entertainment industry, as well as
cultivating the support of organizations (public and
private) and philanthropists committed to social
responsibility, EIF builds awareness and raises funds,
developing and enhancing programs on the local, national and
global level that facilitate positive social change. For
more information, visit www.eifoundation.org.
About the American Association for Cancer
Research
Founded in 1907, the American Association for
Cancer Research (AACR) is the world’s first and largest
professional organization dedicated to advancing cancer
research and its mission to prevent and cure cancer. AACR
membership includes more than 36,000 laboratory,
translational, and clinical researchers; population
scientists; other health care professionals; and cancer
advocates in more than 107 countries and territories around
the world; over 30 percent of members live outside the
United States and Canada. The AACR convenes more than 20
conferences and educational workshops every year, the
largest of which is the AACR Annual Meeting with nearly
19,500 attendees in 2016. The AACR publishes eight
peer-reviewed scientific journals and a magazine for cancer
survivors, patients, and their caregivers and funds
meritorious research directly as well as in cooperation with
numerous cancer organizations. As the Scientific Partner of
SU2C, the AACR provides expert peer review, grants
administration, and scientific oversight of team science and
individual grants. For more information about the AACR,
visit www.AACR.org.
|